Download scientific diagram | Mecanismo de acción de los antibióticos betalactámicos. Tomado de: (Suárez & Gudiol, ). from publication: Determinación. Antibióticos betalactamicos. Dr. Jairo Cerrato Toxicologo clinico. Penicilinas Cefalosporinas Inhibidores de la Carbapenemicos B-lactamasa. ANTIBIOTICOS BETALACTAMICOS. OC. Osvaldo Cabrera. Updated 13 March Transcript. RESISTENCIA. USOS CLINICOS. AMOXICILINA. DE PRIMERA .
|Published (Last):||24 February 2016|
|PDF File Size:||12.52 Mb|
|ePub File Size:||9.30 Mb|
|Price:||Free* [*Free Regsitration Required]|
Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified six systematic reviews including 36 randomized trials addressing this question. Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
There was a problem providing the content you requested
Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Treatment for community-acquired pneumonia in immunocompetent adults is mainly empirical. Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic. Erythromycin compared with a combination of ampicillin and amoxycillin as initial therapy for adults with pneumonia including Legionnaires’ disease.
Are new antibiotics better than beta-lactams for non-critical inpatients with community-acquired pneumonia?. Beta-lactam antibiotics have been traditionally considered first-line therapy.
Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia. Infect Dis Clin Practice. Efficacy and safety of temafloxacin versus those of amoxicillin in hospitalized adults with community-acquired pneumonia. Efficacy and safety betalactaimcos ciprofloxacin in patients with respiratory infections in comparison with amoxycillin.
Epub Sep Betalactakicos phase III comparative study of intravenous levofloxacin and ceftriaxone in community-acquired pneumonia treatment.
Information reported in a systematic review. Moxifloxacin monotherapy versus beta-lactam-based standard therapy for community-acquired pneumonia: Trovafloxacin versus high-dose amoxicillin 1 g three times daily in the treatment of community-acquired bacterial pneumonia.
Study report GFXB Diferencias entre este resumen y otras fuentes. Cochrane Database Syst Rev. Chuard C, Regamey C.
Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: We concluded new antibiotics are not better than beta-lactam antibiotics for the treatment of non-critical inpatients betalatamicos community-acquired pneumonia in relation to clinical failure or adverse effects.
Sobre los desenlaces incluidos en este resumen. Treatment of community-acquired pneumonia: Treatment of community-acquired pneumonia with moxifloxacin: Oral moxifloxacin vs high-dosage amoxicillin in antibiotifos treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults.
Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults.
ANTIBIOTICOS BETALACTAMICOS by Osvaldo Cabrera on Prezi
Medwave se preocupa por su privacidad y la seguridad de sus datos personales. Are new antibiotics better than beta-lactams for non-critical inpatients with community-acquired pneumonia?
Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia. The use of oral temafloxacin compared with a parenteral cephalosporin in hospitalized patients with pneumonia. Scand J Infect Dis. Observation of the therapeutic effects of gatifloxacin on community acquired pneumonia.
Planta farmaceutica para antibioticos betalactamicos by Alejandra Ovalle on Prezi
Vogel F, Lode H. Evaluation of roxithromycin RU versus cephradine in pneumococcal pneumonia. New antibiotics could be more effective but the evidence is not clear until now, and its use could entail greater costs, an increase in bacterial resistance and other adverse effects. Chinese Journal of Antibiotics. Empirical atypical coverage for inpatients with community-acquired pneumonia: Nuestros hallazgos no logran establecer diferencias significativas entre ambas estrategias.
A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia. Sparfloxacin European Study Group. Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia. Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: Clinical Microbiology and Infection. Information reported in a systematic review, Study report La probabilidad que futura evidencia cambie las conclusiones presentadas en este resumen es baja, debido a la certeza de la evidencia.
Safety and efficacy of sequential i. Kinasewitz G, Wood RG. Su principal desarrollo es la base de datos Epistemonikos www.
Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumonia. Int J Antimicrob Agents.